Loading...
The current status of brachytherapy in Europe - A GEC-ESTRO Brachy-HERO survey
Johansen, J. G. Jürgenliemk-Schulz, I. M. Haddad, H. Hannoun-Levi, J. M. Hellebust, T. P. Guix, B. Loessl, K. Pieters, B. Rao, C. Strnad, V.
Johansen, J. G.
Jürgenliemk-Schulz, I. M.
Haddad, H.
Hannoun-Levi, J. M.
Hellebust, T. P.
Guix, B.
Loessl, K.
Pieters, B.
Rao, C.
Strnad, V.
Citations
Altmetric:
Abstract
A survey regarding utilisation of brachytherapy was distributed to European brachytherapy professionals. Eighty replies from 26 countries were received, two of which were outside Europe. The replies showed that brachytherapy is still widely used. The main indications for brachytherapy are gynaecological and prostate cancer, with >80 % of the responding countries performing brachytherapy for these indications. There is on average one brachytherapy centre per 0.8 million inhabitants, ranging from 0.4 per million to 2.3 per million inhabitants. The organisation of brachytherapy on national levels also varies from country to country, with less than half of the countries having a central brachytherapy registry. All in all, the survey shows that brachytherapy still plays a role on modern radiotherapy, but the field could benefit from a stronger collaboration both nationally and internationally.
Description
Date
2024
Publisher
Collections
Files
Keywords
Type
Article
Citation
Johansen JG, Jürgenliemk-Schulz IM, Haddad H, Hannoun-Levi JM, Hellebust TP, Guix B, et al. The current status of brachytherapy in Europe - A GEC-ESTRO Brachy-HERO survey. Clinical and translational radiation oncology. 2025 Jan;50:100883. PubMed PMID: 39584018. Pubmed Central PMCID: PMC11585785. Epub 2024/11/25. eng.